Abstract

The antibody response to the hypervariable region of the E2 protein (HVR1) of hepatitis C virus (HCV) was studied in 5 patients who were infected by a common virus strain during an outbreak in a hemodialysis unit. Two patients resolved the infection, while 3 developed chronic HCV infection. For studying the antibody response to HVRl during the early phase of infection, a Western blot assay using recombinant phage displaying HVRl was developed. The 2 patients with resolving infection had a more rapid antibody response to HVRl than did the patients developing chronic infection. Anti-HVR1 antibodies were repeatedly absent in 1 of the chronically infected patients. Antibodies to recombinant E2 protein occurred later than the anti-HVR1 antibodies and did not correlate with resolution of the infection. Thus, the present results suggest that early appearance of antibodies to the HVRl may predict clearance of HCV infection.

This content is only available as a PDF.
You do not currently have access to this article.